A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma

NCT01378871 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped IND withdrawn

Conditions

Adult T Cell Leukemia
Adult T Cell Lymphoma

Interventions

DRUG: IMTOX-25

Sponsor

Amit Verma